Senate Bill S.4987, FTC Mandated to Report on Foreign Investment in US Pharma

S.4987, introduced in the 119th Congress, would require the Federal Trade Commission to submit a report examining foreign investment activity in the U.S. pharmaceutical industry. The bill was read twice and referred to the Senate Committee on Banking, Housing, and Urban Affairs on July 15, 2026.